Naoya Matsuzaki is a CMC specialist in the pharmaceutical industry with over 14 years of experience in researching and developing innovative medical products. During his engagement in new drug development as an analytical chemist in Astellas Pharma in his early career, he collaborated with many CMOs, CTOs, and business partners globally. He experienced global regulatory submission and commercial product launch. Naoya moved to NS Pharma (a US subsidiary of Nippon Shinyaku) in 2022 and began to work as a CMC US lead for multiple global development projects with various CMC responsibilities, such as a lead of CMC members, CMC RA strategy and clinical trial supply. Naoya has a Ph.D. (Pharmaceutical Science) from the University of Shizuoka and is a 2024 MBA candidate at the University of Massachusetts Lowell.
